OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,250 Shares of Teleflex Incorporated (NYSE:TFX)

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 82.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 11,593 shares of the medical technology company's stock after purchasing an additional 5,250 shares during the quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in Teleflex were worth $2,063,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in TFX. Headlands Technologies LLC acquired a new position in shares of Teleflex in the 4th quarter worth approximately $29,000. Avior Wealth Management LLC grew its holdings in shares of Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after purchasing an additional 125 shares during the last quarter. IFP Advisors Inc grew its holdings in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after purchasing an additional 217 shares during the last quarter. Exchange Traded Concepts LLC increased its stake in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares in the last quarter. Finally, R Squared Ltd bought a new position in shares of Teleflex in the fourth quarter valued at about $64,000. 95.62% of the stock is owned by institutional investors.

Teleflex Price Performance

Shares of TFX stock traded up $2.66 on Friday, hitting $129.15. 542,769 shares of the company's stock were exchanged, compared to its average volume of 637,712. The company has a 50 day moving average of $133.03 and a 200 day moving average of $163.88. The stock has a market cap of $5.71 billion, a P/E ratio of 25.67, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 12 month low of $120.06 and a 12 month high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The company had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm's quarterly revenue was down 5.0% compared to the same quarter last year. During the same period last year, the company posted $3.21 EPS. On average, equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio is currently 42.90%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. Piper Sandler reiterated a "neutral" rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Mizuho set a $155.00 price target on shares of Teleflex in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.